COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

TRANSEURO Open Label Transplant Study in Parkinson's Disease (TRANSEURO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01898390
Recruitment Status : Active, not recruiting
First Posted : July 12, 2013
Last Update Posted : April 19, 2019
Lund University
Cardiff University
Imperial College London
University College, London
University Hospital Freiburg
Life Science Governance Institute
Assistance Publique - Hôpitaux de Paris
Institut National de la Santé Et de la Recherche Médicale, France
Life Technologies Ltd, part of Thermo Fisher Scientific
Cambridge Cognition Ltd
Skane University Hospital
Imanova Limited
Information provided by (Responsible Party):
Prof Roger Barker, University of Cambridge

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 2021